Finding 398698 (2023-005)

Significant Deficiency
Requirement
I
Questioned Costs
-
Year
2023
Accepted
2024-05-29

AI Summary

  • Core Issue: The Organization lacks effective internal controls for verifying suspension and debarment compliance before engaging with vendors.
  • Impacted Requirements: Non-compliance with 2 CFR 200.303(a) and 31 CFR 19.300 regarding verification of vendor eligibility.
  • Recommended Follow-Up: Implement and document controls to ensure suspension and debarment checks are completed prior to vendor agreements.

Finding Text

2023-005: Inadequate Internal Controls over Suspension and Debarment Compliance Requirement U.S. Department of Health and Human Services Federal Programs: Health Center Program Cluster (ALN numbers 93.224/93.527) (Federal Award Year 2023) and Advanced Nursing Education Workforce Grant Program (ALN number 93.247) (Federal Award Year 2023) Repeat Finding: No Criteria: 2 CFR 200.303(a) requires that each non-Federal entity must "Establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award." The Organization does not have effective suspension and debarment controls in place. 31 CFR 19.300 requires that "When you enter into a covered transaction with another person at the next lower tier, you must verify that the person with whom you intend to do business is not excluded or disqualified." Condition: When the Organization entered into covered transactions, it did not verify that the entity was not suspended or debarred or otherwise excluded. While the Organization does have an internal control policy in place regarding the Simplified Registration Services (SAM) exclusion verifications of suspended or debarred entities, the Organization did not always adhere to the policy when entering into covered transactions. Additionally, the policy is vague and does not include details about maintaining evidence of actions taken to ensure proper suspension and debarment requirements are met. Cause: The Organization does not have procedures in place to ensure suspension and debarment checks are completed prior to entering into purchase or service agreements with vendors. Evidence of actions taken to ensure proper suspension and debarment requirements were not being maintained by the Organization. Effect: Failing to have the appropriate controls in place may result in vendors who are suspended or debarred receiving federal funds. Recommendation: We recommend that management implement controls to ensure suspension and debarment checks are completed and documented prior to entering into purchase or service agreements with vendors. View of responsible officials of the auditee: Management agrees with the finding and recommendation.

Categories

Procurement, Suspension & Debarment

Other Findings in this Audit

  • 398693 2023-005
    Significant Deficiency
  • 398694 2023-005
    Significant Deficiency
  • 398695 2023-005
    Significant Deficiency
  • 398696 2023-005
    Significant Deficiency
  • 398697 2023-003
    Material Weakness
  • 398699 2023-004
    Material Weakness
  • 398700 2023-004
    Material Weakness
  • 398701 2023-004
    Material Weakness
  • 398702 2023-002
    Material Weakness
  • 398703 2023-002
    Material Weakness
  • 398704 2023-002
    Material Weakness
  • 398705 2023-002
    Material Weakness
  • 398706 2023-002
    Material Weakness
  • 975135 2023-005
    Significant Deficiency
  • 975136 2023-005
    Significant Deficiency
  • 975137 2023-005
    Significant Deficiency
  • 975138 2023-005
    Significant Deficiency
  • 975139 2023-003
    Material Weakness
  • 975140 2023-005
    Significant Deficiency
  • 975141 2023-004
    Material Weakness
  • 975142 2023-004
    Material Weakness
  • 975143 2023-004
    Material Weakness
  • 975144 2023-002
    Material Weakness
  • 975145 2023-002
    Material Weakness
  • 975146 2023-002
    Material Weakness
  • 975147 2023-002
    Material Weakness
  • 975148 2023-002
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
93.527 Affordable Care Act (aca) Grants for New and Expanded Services Under the Health Center Program $4.77M
93.224 Covid-19 - Consolidated Health Centers (community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) $2.49M
93.527 Covid-19 - Affordable Care Act (aca) Grants for New and Expanded Services Under the Health Center Program $1.16M
93.224 Consolidated Health Centers (community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) $581,743
93.788 Opioid Str $383,798
93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (elc) $308,830
93.526 Affordable Care Act (aca) Grants for Capital Development in Health Centers $288,337
93.566 Refugee and Entrant Assistance_state Administered Programs $170,000
93.994 Maternal and Child Health Services Block Grant to the States $153,840
93.332 Cooperative Agreement to Support Navigators in Federally-Facilitated and State Partnership Marketplaces $128,294
93.323 Covid-19 - Epidemiology and Laboratory Capacity for Infectious Diseases (elc) $61,089
93.247 Advanced Nursing Education Grant Program $59,275
93.217 Family Planning_services $53,680
93.110 Maternal and Child Health Federal Consolidated Programs $17,500